The document discusses how pharmaceutical companies can leverage social media to enhance pharmacovigilance and patient safety. It proposes a 4-step social media model: 1) establish keywords related to side effects, 2) listen to patient conversations on social media, 3) generate reporting and analytics on collected data, 4) respond to patient concerns. Adopting this approach allows companies to identify risks early, minimize reputation risks, and manage adverse events, helping boost patient safety.